In pancreatic cancer, macrophage-specific deletion of AhR or AhR inhibition impaired tumor growth, improved the efficiency of checkpoint blockade therapy, and increased infiltration of CD8+ T cells [19]. The gene discussed is CD8A; the disease is neoplasm.